<html><!-- #BeginTemplate "/Templates/htct_template.dwt" -->
<head>
<link rel="STYLESHEET" type="text/css" href="/css/revistas.css">
<!-- #BeginEditable "doctitle" --> 
<title>HTCT - Instructions to authors</title>
<!-- #EndEditable --> 
</head>
<style>
.rodape {  font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 8pt; color: #666666; text-align: center; font-weight: normal; font-style: normal}
</style><body>
<table width="100%" border="0">
  <tr> 
    <td width="30%" align="center" valign="top"> 
      <p><!-- #BeginEditable "link" --><a href="/scielo.php?script=sci_serial&pid=2531-1379&lng=en&nrm=iso"><img
    src="/img/revistas/htct/plogo.gif" border="0"></a><!-- #EndEditable --></p>
      <p align="center" class="issn">ISSN 2531-1379<!-- #BeginEditable "impressa" --><i> 
        printed version</i><!-- #EndEditable --> 
        <br>
        ISSN 2531-1387<!-- #BeginEditable "on-line" --><i> 
        on-line version</i><!-- #EndEditable --> 
      </p>
    </td>
    <td width="70%" valign="top" align="left"><!-- #BeginEditable "topo" --> 
      <blockquote> 
        <p class="titulo">INSTRUCTIONS TO AUTHORS</p>
      </blockquote>
      <ul>
        <li><a href="#01">Scope and Policy</a></li>
        <li><a href="#02">Form and preparation of manuscripts</a></li>
        <li><a href="#03">Send of the manuscripts</a></li>
        </ul>
      <!-- #EndEditable --></td>
  </tr>
</table>
<!-- #BeginEditable "texto" --> 
<p>&nbsp;</p>
<p class="subtitulo"><b><a name="01">Scope and Policy</a></b></p>
<table border="0" width="100%">
  <tr> 
    <td width="15%"></td>
    <td width="70%"> 
      <p>The Hematology, Transfusion and Cell Therapy Journal  (ISSN 2531-1379), the official scientific publication of the Associa&ccedil;&atilde;o Brasileira  de Hematologia, Hemoterapia e Terapia Celular, Sociedade Brasileira de Transplante  de Medula &Oacute;ssea, Associazione Italo-Brasiliana di Ematologia and Sociedade Brasileira  de Oncologia Pedi&aacute;trica aims to promote scientific development in Hematology, Transfusion  Medicine and related areas. All manuscripts, after initial acceptance by the  editors, will be sent to at least two peer reviewers for analysis. Anonymity is  guaranteed throughout the evaluation process. When considered necessary, a list  of modifications will be sent to the authors to correct their work or justify their  decision not to do so. The responsibility for opinions expressed in articles is  solely of the authors.</p>
      <p>Manuscripts should not be submitted simultaneously  to more than one journal. This is an Open Access journal where articles are distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-nd/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.</p>
The journal publishes  the following sessions: Original Article, Special Article, Review Article, Updates  in the Specialty, Case report, Letter to the Editor, Images in Clinical Hematology,  Editorial, Scientific Comment and What is the Evidence. Other types of publications  of interest in the area will be published at the discretion of the editors. All  articles will be published in English. </td>
    <td width="15%"></td>
  </tr>
</table>
<p>&nbsp;</p>
<p class="subtitulo"><a name="02"><b>Form and preparation of manuscripts</b></a></p>
<table border="0" width="100%">
  <tr> 
    <td width="15%"></td>
    <td width="70%"> 
      <p><strong>General information</strong><p>
For any manuscript to be evaluated,  it must be accompanied by the following documentation:</p>
      <ul type="disc">
        <li>Conflict of interest: Situations that may improperly       influence the development or the conclusions of the work: participation in       drug- or equipment-producing companies cited or used in the work, as well as       competitors of these companies should be mentioned. Financial assistance, payments       received for consultancies, relationships related to employment, etc. are also       considered sources of conflict.</li>
        <li>Approval of the study by a Research Ethics Committee       recognized by a National Research Ethics Committee such as CONEP;</li>
        <li>Articles that deal with clinical research involving       human beings must include a statement in the Methods Section that all study       participants signed an <u>informed consent form</u>. Authors should also confirm       that the study was conducted in accordance with the Helsinki Declaration as       revised in 2008;</li>
        <li>For works involving animal experimentation, the authors       should confirm in the Methods Section that the study followed the rules contained       in the Ethical Code for Animal Experimentation of the Council for International       Organizations of Medical Sciences (CIOMS) [WHO Chronicle 1985; 39 (2): 51-6]       and those produced in Brazil, the principles of the Brazilian College of Animal       experimentation - COBEA (<a href="http://www.scielo.br/revistas/rbhh/www.cobea.org.br" target="_blank">www.cobea.org.br</a>). Authors       must complete the Declaration - <u>Statement of Human and Animal Rights</u>.</li>
      </ul>
      <p>All randomized controlled trials  and clinical trials submitted for publication must be registered in a clinical trials  database. This is a guideline of the International Clinical Trial Registry Platform  (ICTPR) of the World Health Organization (WHO) and the International Committee of  Medical Journal Editors (ICMJE). The instructions for registration are available  at http: <a href="http://www.scielo.br/revistas/rbhh/www.icmje.orgclintrialup.htm" target="_blank">www.icmje.orgclintrialup.htm</a> and registration can be attained  in the Clinical Trials Database of the National Library of Medicine available at <a href="http://clinicaltrials.gov/ct/gui" target="_blank">http://clinicaltrials.gov/ct/gui</a>.<p>
        <strong>Technical requirements</strong> 
      <blockquote>
        <p>
          <strong>1. </strong>Article identification: a) A concise however informative title; b)  Complete names of authors without abbreviations and their institutions; c) Official  name of the institution(s) to which the work should be attributed; d) Name, full  address including telephone and e-mail of corresponding author; e) financial support  (if any).</p>
        <p>
          <strong>2. </strong>Abstract and keywords: Abstract in English without abbreviations of  not more than 250 words. For Original Articles this should be structured with background,  method, main results and conclusion. For the other article types, the abstract need  not be structured but should contain information illustrating the importance of  the work. Specify up to five keywords, which define the theme of the paper. The  keywords should be based on MeSH (Medical Subject Headings) from the National Library  of Medicine available at: <a href="http://decs.bvs.br/" target="_blank">http://decs.bvs.br</a>.  For clinical trials, indicate the International Clinical Trials Registry Number  below the summary.</p>
        <p>
          <strong>3. </strong>Manuscript content: <strong>a) Original Article:</strong> Used to publish the  results of scientific research, it must be original and should comprise the following:  Introduction, Objective, Method, Results, Discussion, Conclusion and References.  The work should not exceed 4000 words (including references), up to 6 authors, up  to 7 tables, illustrations and photos and up to 30 references; <strong>b) Special Article:</strong> With the same structure as original articles, Original Articles are reclassified  by the Editor depending on their importance; <strong>C) Review Articles: </strong>narrative  reviews addressing an important issue in the specialty. These articles should not  exceed 5000 words (including references), a maximum of 7 tables, Figures and Photos  and up to 60 references; <strong>d) Update in the Specialty:</strong> on a theme, method,  treatment, etc. It must contain a brief history of the topic, its current state  of knowledge and the reasons for the work; study methods (data sources, selection  criteria), hypotheses, study lines, etc., criteria similar to review articles: <strong>e)  Case Report:</strong> should have an introduction with a brief literature review, a description  of the case showing significant results for the diagnosis and differential diagnoses  (if any), discussion or comments and references. It should not exceed 1800 words,  two tables, illustrations and photographs, up to four authors and a maximum of ten  references: <strong>f) Letters to the Editor:</strong> a maximum of 1000 words (including  references), three authors, and two illustrations: <strong>g) Images in Clinical Hematology: </strong>Maximum 100 words, three authors and three references: <strong>h) Scientific comments:</strong> will only be accepted by invitation of the editors.</p>
        <p>
          <strong>4 </strong><strong>Acknowledgements</strong>: Should be addressed to collaborators who deserve recognition, but  whose participation does not justify their inclusion as an author such as technical  assistants, as well as financial support received.</p>
        <p>
          <strong>5. </strong><strong>References</strong>: Use Vancouver style in all categories of articles, the citations  must be numeric and inserted according to the order of entry in the text.</p>
      </blockquote>
      <p>
        <strong>Examples of references:</strong> <p>
        <strong>Printed documents</strong> <p>
        <strong>Journals:</strong> Padley DJ, Dietz AB, Gastineau DA. Sterility testing of hematopoietic  progenitor cell products: a single-institution series of culture-positive rates  and successful infusion of culture-positive products. Transfusion. 2007;47(4):636-43.<p>
        <strong>Books:</strong> Chalmers J. Clinician&rsquo;s manual on blood pressure and stroke prevention.  3rd ed. London: Science Press; 2002. 70 p.<p>
        Richardson MD, Warnock DW. Fungal  Infection Diagnosis and Management. 2nd ed. Oxford: Blackwell Science Ltd Editorial  Offices; 1997.249 p.<p>
  <strong>Book chapters:</strong> F. Reyes. Lymphocyte differentiation. In P Solal-C&eacute;ligny, N Brousse,  F Reyes, C Gisselbrecht, B Coiffier. Non-Hodgkin`s Lymphomas. Paris: &Eacute;ditions Frison-Roche;  1993. p.19-29.<p>
  <strong>Annals:</strong> Souza AM, Vaz RS, Carvalho MB, Arai Y, Hamerschilak N. Preval&ecirc;ncia  de testes sorol&oacute;gicos relacionados &agrave; hepatitis B e n&atilde;o-A, n&atilde;o-B em doadores de sangue.  In: 19&ordm; Congresso Brasileiro de Hematologia e Hemoterapia / 26&ordm; Congresso da Sociedade  Brasileira de Hematologia e Hemoterapia; 2003 Ago 6-9; S&atilde;o Paulo, 2003. Anais<strong>.</strong> p.103.<p>
  <strong>Theses:</strong> Sandes AF. Caracteriza&ccedil;&atilde;o imunofenot&iacute;pica da diferencia&ccedil;&atilde;o eritrocit&aacute;ria,  granuloc&iacute;tica e megacari&oacute;tica em pacientes com s&iacute;ndromes mielodispl&aacute;sicas [thesis].  S&atilde;o Paulo: Universidade Federal de S&atilde;o Paulo; 2009. 126p.<p>
  <strong>Electronic documents</strong> <p>
  <strong>Articles in Periodicals:</strong> Almeida ID, Coitinho AS, Juckowsky CA, Schmalfuss T, Balsan AM, R&ouml;hsig  LM. Controle de esterilidade de produtos de c&eacute;lulas progenitoras hematopo&eacute;ticas  do sangue perif&eacute;rico. Rev Bras Hematol Hemoter [Internet] 2010 [cited 2010 Jun 10];  32(1):23-8. Available from: <a href="http://www.scielo.br/pdf/rbhh/v32n1/aop03010.pdf" target="_blank">http://www.scielo.br/pdf/rbhh/v32n1/aop03010.pdf</a><p>
  <strong>Books: </strong>Walker HK, Hall WD, Hurst JW, editors. Clinical methods. The history,  physical, and laboratory examinations. 3rd ed. [Internet]. Boston: Butterworths;  1990. [cited 2010 Jun 10]. Available from: <a href="http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=cm" target="_blank">http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=cm</a><p>
  <strong>Illustrations and photos: </strong>Must have a resolution of at least 1000 dpi. Color figures should be  in CMYK and will be published in color only if essential and must be in TIFF, JPEG  or CDR format. Do not send the figures within the text.<p>
  <strong>Tables:</strong> should be numbered consecutively using Arabic numerals and cited in  the text in numerical order. </p>    </td>
    <td width="15%"></td>
  </tr>
</table>
<p align="left">&nbsp;</p>
<p class="subtitulo"><b><a name="03">Send of the manuscripts</a></b></p>
<table border="0" width="100%">
  <tr> 
    <td width="15%"></td>
    <td width="70%"> 
      <p><strong>Submission</strong> 
      <p>
The submission of the manuscript  must be via the website of the Hematology, Transfusion and Cell Therapy, <a href="http://www.scielo.br/revistas/rbhh/www.rbhh.org" target="_blank">www.rbhh.org</a> or <a href="https://ees.elsevier.com/htct">https://ees.elsevier.com/htct</a><p>
When a manuscript is accepted for  publication, the author(s) will be requested to complete a conflict of interest  form which must be sent to the editorial office.<p>
It is the responsibility of authors  to obtain written permission to reproduce any previously published data included  in the manuscript.<p>
The editors can publish papers that  do not exactly follow the instructions after careful evaluation always taking into  account the interests of the readership.<p>
<strong>Correspondence address:</strong><p>
Fernando Ferreira Costa<br>
Rua Dr. Diogo de Faria, 775/ conj. 114 &ndash; Vila Clementino<br>
S&atilde;o Paulo/SP<br>
CEP: 04037-002
<br>
Telephones: (11) 2369-7767 / (11) 2338-6764
<a href="http://www.scielo.br/revistas/rbhh/abhh@abhh.org" target="_blank">abhh@abhh.org</a>
<p>
There is no fee for submission and  evaluation articles.</td>
    <td width="15%"></td>
  </tr>
</table>
<p>&nbsp;</p>
<p align="center">[<a href="/scielo.php?script=sci_serial&pid=2531-1379&lng=en&nrm=iso">Home</a>] 
  [<a href="iaboutj.htm">About the journal</a>] [<a href="iedboard.htm">Editorial 
  board</a>] [<a href="isubscrp.htm">Subscriptions</a>]</p>
<hr size="1" noshade>
<p class="rodape"><a href="http://creativecommons.org/licenses/by-nc/3.0/" class="rodape"><img alt="Creative Commons License" style="border-width:0" src="http://i.creativecommons.org/l/by-nc/3.0/80x15.png" border="0"></a> 
  All the content of the journal, except where otherwise noted, is licensed under 
  a <a rel="license" href="http://creativecommons.org/licenses/by-nc/3.0/" class="rodape">Creative 
  Commons License</a></p>
<!-- #EndEditable --> 
<p><a name="end"></a> 
</p>
<p align="center" class="rodapep">Rua, n&uacute;mero, complementos Bairro teste<br>
  Caixa Postal<br>
  CEP Cidade Estado Pa&iacute;s<br>
  Tel.:<br>
  Fax:<br>
  Tel./Fax:</p>
<p align="center"><img
src="/img/revistas/e-mailt.gif" border="0"><br>
  <a href="mailto:e-mail">e-mail</a></p>
</body>
<!-- #EndTemplate --></html>